The optimization of recombinant antibody production in Chinese Hamster Ovary (CHOK1) cells is a crucial aspect of biopharmaceutical development. To maximize yield, various approaches are employed, including protein engineering of the host cells and optimization of media conditions. Additionally, utilization of advanced fermenters can significantl